• Home
  • Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells.

Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells.

Author List
Kosaka A, Ohkuri T, Okada H
Publication
Cancer immunology, immunotherapy : CII
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1182173
Publication Year
2014
PubMed ID
24878890
Publication Title
Kosaka A, Ohkuri T, Okada H. Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells. Cancer Immunol Immunother. 2014 Aug; 63(8):847-57.